Pacira | PCRX - Ebitda





Ebitda تغيير تاريخ
Astellas Pharma JPY 98.93B 84.75B 2026-03
Bristol-Myers Squibb USD 2.88B 1.36B 2025-12
Cara Therapeutics USD -2.39M 3.16M 2025-03
Coherus Biosciences USD -43.33M 4.7M 2025-09
Heron Therapeutics USD -3.88M 5.63M 2024-09
Ironwood Pharmaceuticals USD 81.81M 31.71M 2025-09
J&J USD 7.19B 2.32B 2025-12
Ligand Pharmaceuticals USD 66.78M 83.54M 2025-12
Nektar Therapeutics USD -31.81M 70K 2023-09
Novo Nordisk DKK 34.72B 2.57B 2026-03
Omeros USD -47.96M 7.39M 2023-09
Pacira USD 40.24M 1.53M 2026-03
Perrigo USD 141.6M 1.34B 2026-03
Pfizer USD 5.99B 5.23B 2026-03
Supernus Pharmaceuticals USD 29.23M 19.27M 2026-03
Teva Pharmaceutical Industries USD 1.06B 582M 2026-03
Xeris Pharmaceuticals USD 25.09M 7.67M 2025-12
Xoma USD 2.52M 7.98M 2024-06
Zoetis USD 939M 101M 2025-12